Your ADHD, Your Hypermobile Joints, and Your Chronic Pain Are Not Three Separate Problems

If you have ADHD and you also live with hypermobile or unstable joints, unexplained widespread pain, crushing fatigue, or dizziness when you stand up, there is a very good chance that every specialist you have ever seen has treated these as entirely separate problems. Your psychiatrist handles your ADHD. Your rheumatologist handles your joints. Your pain clinic handles your fibromyalgia. And somewhere in the space between all of them, nobody has connected the dots. Emerging research is now suggesting that for a significant subset of neurodivergent people, these are not separate problems. They are multiple expressions of the same underlying biology, linked by connective tissue genetics, autonomic nervous system dysregulation, and shared inflammatory pathways that medicine is only now beginning to map in the same room.

The Numbers Nobody Is Talking About

A cross-sectional screening study published in 2026 in Scientific Reports examined 958 adults with persistent chronic pain across 13 multidisciplinary pain centres in Japan. Researchers found that adults with chronic pain were 2.4 times more likely to screen positive for ADHD traits than the general population (Kasahara et al., 2026, Scientific Reports). Among people reporting extremely severe pain, scoring 9 or 10 out of 10, 27.4% screened positive for ADHD traits. The lead researcher noted directly that in clinical practice, people with chronic pain who fail conventional treatments frequently show characteristics common to ADHD, including inattention, impulsivity, and difficulties with emotional regulation. No relationship was found between autistic traits and pain severity in this study, which makes the ADHD-specific signal even more striking.

A separate case-control study of adults with chronic pain and chronic fatigue found adjusted odds ratios of 12.9 for likely ADHD in that group compared to a non-clinical comparison population. Critically, the researchers tested whether joint hypermobility, a marker of variant connective tissue, mediated this relationship. It did. Joint hypermobility partially explained the association between neurodivergence and chronic pain or fatigue. The connection was not just a coincidence of comorbidities sitting beside each other in the same person. The connective tissue was doing some of the explanatory work.

What Is Hypermobile EDS and Why Does It Matter Here?

Hypermobile Ehlers-Danlos syndrome (hEDS) and the related hypermobility spectrum disorder (HSD) are conditions involving lax, stretchy connective tissue throughout the body. Connective tissue is not just about joints. It is the structural matrix present in virtually every organ system, including the blood vessel walls, the gut, the skin, the autonomic nerve sheaths, and the support scaffolding around every internal organ. When the proteins that build connective tissue, most notably various collagen subtypes and their regulatory proteins, do not function as expected, the downstream effects are systemic.

The visible hallmarks of hEDS include joints that flex beyond typical range, soft or velvety skin, and a history of frequent sprains, dislocations, or musculoskeletal pain disproportionate to the activity that caused it. The less visible hallmarks are where the ADHD connection starts to become legible: chronic fatigue, headaches, dizziness on standing, gastrointestinal dysmotility, difficulty regulating body temperature, and a dysregulated autonomic nervous system. A study of 99 adults with generalized joint hypermobility or hEDS found that 47% screened above threshold for autism and 20% for ADHD. All measures were significantly correlated: the more connective tissue features a person had, the higher their neurodivergent trait scores. The mechanism that best explained this relationship was autonomic reactivity, and it held even after anxiety levels were controlled for.

The more connective tissue features a person had, the higher their neurodivergent characteristics. Autonomic reactivity was the mechanistic thread that connected variant connective tissue with neurodivergence, not anxiety, not psychological distress. Biology.

Is This Actually Genetic? What the Research Is Saying

The specific genetic architecture of this overlap is still being mapped, and it is worth being honest about what is established versus what is emerging. No single gene has been identified as a shared cause of ADHD, hEDS, and fibromyalgia. What research has established is a pattern of co-occurrence far too consistent to be coincidental, combined with mechanistic pathways that could plausibly explain a shared biological substrate.

ADHD has a heritability estimated at around 70 to 80%, placing it among the most heritable of neurodevelopmental conditions. Genome-wide association studies have identified hundreds of contributing genetic variants, many of them involving dopaminergic and noradrenergic signalling genes, but also genes relevant to synaptic development, immune regulation, and structural biology. Hypermobile EDS is also heritable, though its specific genetic cause remains unidentified. Unlike classical EDS subtypes, which carry known mutations in collagen genes such as COL5A1, hEDS does not yet have a confirmed single-gene explanation. Proteomic profiling studies of people with hEDS and HSD have identified shared protein signatures that include evidence of aberrant mast cell activation and persistent low-grade inflammation, suggesting the condition involves immune and inflammatory dysregulation well beyond structural laxity alone.

The working model that is gaining traction in research is one of shared polygenic vulnerability: inherited biological differences that simultaneously affect connective tissue architecture, autonomic nervous system calibration, sensory processing thresholds, and catecholamine regulation. These are not independent systems. Dopamine and norepinephrine, the neurotransmitters most directly implicated in ADHD, also regulate key aspects of autonomic function. A nervous system built on a different structural and biochemical foundation may express that difference across multiple domains at once, producing conditions that look unrelated from the outside because they fall into different medical specialties, but are downstream of the same upstream biology.

The Autonomic Nervous System: Where ADHD and Body Symptoms Converge

Postural Orthostatic Tachycardia Syndrome, or POTS, is a form of dysautonomia in which the autonomic nervous system fails to adequately regulate heart rate and blood pressure on standing. It is significantly more common in people with hEDS and HSD than in the general population. Traits include a rapid heart rate on standing, dizziness, nausea, cognitive fog, fatigue, and post-exertion crashes that can last days. The cognitive features of POTS overlap substantially with the cognitive profile of ADHD: difficulty concentrating, working memory gaps, difficulty sustaining attention, and what people with POTS describe as thinking through fog. Many people with POTS have received an ADHD diagnosis. Many people with ADHD who experience these physical features have never been assessed for dysautonomia at all.

The overlap is not just symptomatic. The same norepinephrine systems that are dysregulated in ADHD also govern a significant portion of autonomic function. ADHD medications acting on norepinephrine, including atomoxetine and certain stimulant formulations, have in some cases improved POTS traits alongside cognitive ones. This pharmacological overlap reflects shared neurobiological substrate rather than coincidence. The body and the brain are running on the same catecholamine infrastructure, and when that infrastructure is variant, the effects appear in both domains simultaneously.

Where Fibromyalgia Fits Into This Picture

Fibromyalgia is a condition of widespread chronic pain, fatigue, and sleep disruption, generally understood through the lens of central sensitisation: the central nervous system’s pain-processing mechanisms become amplified, producing pain that persists far beyond what any local tissue damage would explain. Pain signals that would be manageable in a differently calibrated nervous system become persistent and debilitating once that sensitisation is established.

Central sensitisation has a direct parallel in how neurodivergent nervous systems process sensory information generally. Sensory processing differences are now recognised as a feature of ADHD, not only autism, and the neural mechanisms that produce heightened sensory sensitivity in neurodivergent brains likely share architecture with the mechanisms that amplify pain signals in fibromyalgia. Research examining autism and chronic pain has found that fibromyalgia is more common in autistic people than in the general population, and that the central sensitisation model maps closely onto broader patterns of sensory over-reactivity documented in neurodivergent presentations. Adding ADHD into that picture does not simplify things, but it does make them more coherent: a nervous system that processes sensory signals differently from the outset may be more vulnerable to the kind of central sensitisation that drives fibromyalgia.

The overlap between fibromyalgia and hEDS is already established in rheumatology: many people with hEDS also meet fibromyalgia criteria, and distinguishing between the two can be clinically difficult. Adding the neurodivergent dimension produces a picture in which connective tissue instability creates structural sources of pain, central sensitisation amplifies that pain beyond what the structural damage alone would predict, and the neurodivergent nervous system may have been physiologically primed for that amplification from the beginning. None of these pathways are yet fully mapped, but the convergence across multiple independent research lines is no longer easy to dismiss.

The Gender Dimension That Makes This Worse

ADHD, hEDS, and fibromyalgia are all significantly underdiagnosed in women, and for overlapping reasons. ADHD in women tends to present with more internalised traits: inattentiveness, anxiety, emotional dysregulation, and the kind of high-functioning exhaustion that looks like coping rather than struggling. hEDS is diagnosed predominantly in women, but the typical journey to that diagnosis stretches across years, sometimes a decade, of traits dismissed as anxiety, hypochondria, or attention-seeking. Fibromyalgia and chronic fatigue conditions carry the same dismissal history, with women disproportionately told their presentations are psychological before any thorough physical workup is completed.

A large study of 1,754 people with hEDS or HSD found that participants with high levels of autistic traits, and autistic participants themselves, had more severe hypermobility features and were more likely to report that their physical presentations had been attributed to psychological causes rather than investigated seriously. The diagnostic delay compounds the harm. Each year of unrecognised pain and dysautonomia represents additional physiological load on a nervous system that is already running at elevated cost. The ADHD body pillar explores more of how hormonal and physiological variables interact with ADHD presentation across the lifespan, including the ways female-pattern ADHD is systematically missed at every stage of the diagnostic process.

Why Your ADHD Gets Worse During a Flare

People with ADHD who also live with chronic pain consistently report that their ADHD traits become significantly worse during pain flares. Working memory narrows, task initiation becomes nearly impossible, emotional regulation frays faster, and the cognitive overhead of managing the body leaves almost nothing available for anything else. The standard explanation is distraction: of course it is harder to concentrate when you are in pain.

That explanation is not wrong, but it substantially undersells what is happening neurobiologically. Chronic pain activates the body’s stress response systems, and those same systems directly modulate the prefrontal-striatal circuits that underlie executive function in ADHD. When the body is managing a significant pain load, inflammatory signalling increases, cortisol and norepinephrine release patterns shift, and the neurotransmitter systems most relevant to ADHD executive function become less effective. The brain is not being distracted. It is having its core neurochemical resources actively redistributed away from executive planning and toward threat management and physiological stabilisation. This is a biological process, not a motivational failure. The article Your Brain Can’t Execute When Your Body Is Under Siege covers this neurobiological resource competition in depth. The relevant point here is that the physiological cost of a pain or fatigue flare is not additive for a person with ADHD: it is multiplicative, because it targets the exact systems that were already the most resource-constrained.

It is not that pain distracts an ADHD brain. It is that pain and ADHD compete for the same neurological resources, and when both are active simultaneously, there is not enough left for either to function adequately.

What This Means for Getting Actually Useful Medical Care

Getting clinicians to see this picture requires patience that people managing three exhausting conditions simultaneously should not have to spend. But the research exists now, and it is findable and citable. Researchers studying this overlap have explicitly recommended that pain clinicians routinely screen for ADHD, because unrecognised ADHD in someone with chronic pain predicts worse treatment outcomes and lower responsiveness to standard pain interventions. The same case is worth making in reverse: ADHD specialists treating people with significant fatigue, widespread pain, or standing intolerance should be factoring in the possibility of connective tissue disorder and dysautonomia, rather than attributing everything to anxiety or medication side effects.

If you suspect hEDS or HSD, a referral to a rheumatologist or geneticist experienced in connective tissue disorders is the formal route, though waiting times are long and self-advocacy is usually required to get there. A physiotherapist trained specifically in hypermobility can provide functional support, stabilisation strategies, and joint protection guidance without waiting for a formal diagnosis. If you suspect POTS, a lying-to-standing heart rate test is a non-invasive starting point that can be done in a GP office: lie flat for ten minutes, stand, and measure heart rate at one, three, and ten minutes. An increase of 30 or more beats per minute in the first ten minutes is a recognised diagnostic indicator. For chronic widespread pain, a pain medicine specialist working within a biopsychosocial model rather than a purely mechanical framework will be far better placed to factor in the ADHD-related pain amplification pathways that make standard treatments less effective in this population.

The Research Gap and Why You Were Right to Connect These

The science is not yet complete. The genetic architecture linking ADHD, variant connective tissue, and autonomic dysfunction has not been fully resolved, and the causal arrows between these conditions are still being traced. What exists now is a strong epidemiological signal across multiple independent studies, a mechanistic framework with real explanatory power, and a growing body of clinical observation from practitioners who have been noticing this cluster for years before the formal research arrived to describe it.

For the person who has spent years being told that their pain is unrelated to their brain, their fatigue is just anxiety, their joint instability is just deconditioning, and their ADHD is the only real diagnosis worth taking seriously, this body of research offers something that has been missing: a coherent explanation that validates all of it at once. You were not imagining the connection. You were experiencing a real biological cluster that medicine’s specialisation structure had sorted into separate boxes and assigned to separate clinicians who were not communicating with each other.

The research is running behind the lived experience, as it usually does with conditions that are complex, predominantly affect women, and sit at the intersection of multiple specialties. But it is catching up. For anyone navigating the energy and recovery costs of this kind of physiological complexity, the ADHD energy pillar addresses how burnout, nervous system regulation, and sustainable recovery function when your starting baseline is not a neurotypical body in a neurotypical physiological state.